共 50 条
- [1] Effectiveness, safety and durability of vedolizumab in active moderate-severe Crohn's Disease [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I489 - I490
- [2] The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (08): : 1147 - 1155
- [3] Ustekinumab versus Vedolizumab for Moderate to Severe Crohn's Disease [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S393 - S394
- [5] Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn’s Disease in China [J]. Advances in Therapy, 2021, 38 : 4233 - 4245
- [7] The Value of Vedolizumab as Rescue Therapy in Moderate-Severe Crohn's Disease Patients with Adalimumab Non-response in the USA [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 (08): : 669 - 675